Med J Aust
Focus GroupsHealth Knowledge, Attitudes, PracticeQualitative Research
Dr. David Scott III, MD
NPI1730281452PAC ID0345149233
- Medicare services, 2024
- 343
- Medicare patients, 2024
- 54
- Part D claims, 2024
- 2,166
- Publications
- 247
- Clinical trials
- 4
- Practice address
- 1 Cross Island Plz, Rosedale, NY 11422
- Practice phone
- Call (718) 276-4750
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nephrology and Internal Medicine Specialist
Rosedale, New York
Find Dr. Scott's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Scott III is a nephrologist in Rosedale, New York
Dr. Scott practices at Nephrology and Internal Medicine Specialist in Rosedale, New York.
Dr. Scott's NPI, 1730281452, was assigned on September 2, 2006. Dr. Scott graduated from Tufts University School of Medicine in 1985. Dr. Scott holds New York license 176037-1.
NPI and contact details
- NPI
- 1730281452NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0345149233
- NPI enumeration date
- September 2, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (718) 276-4750
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 67
- Medical school graduation
- 1985
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Scott III practices at Nephrology and Internal Medicine Specialist in Rosedale, New York
Dr. Scott's primary practice is Nephrology and Internal Medicine Specialist, at 1 Cross Island Plz, Rosedale, NY 11422 in Queens County. The practice phone is (718) 276-4750.
- Nephrology and Internal Medicine Specialist1 Cross Island Plz, Rosedale, NY 11422 · Queens CountyPhone(718) 276-4750
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. David Scott III is affiliated with 3 sites of care
Dr. Scott's primary practice is Nephrology and Internal Medicine Specialist in Rosedale, New York. Dmand AI also links Dr. Scott to 1 dialysis center and 1 physician office, each named with a free account.
Nephrology and Internal Medicine SpecialistPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. David Scott III's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scott practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nephrology and Internal Medicine Specialist | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Scott practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Scott III is one of 914 nephrologists in New York
Nephrology is Dr. Scott's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Scott is licensed in New York.
Specialties and state licenses
- Nephrology, New YorkPrimary
Nephrologists near Dr. Scott
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Scott III billed Medicare for 343 services in 2024
CMS data shows 343 Medicare services from Dr. Scott across 4 procedure codes in 2024, for 54 Medicare patients. Medicare paid $33,158 for them. Every service was in an office.
Medicare services, 2024343
Medicare patients54
Paid by Medicare$33,158
Procedure codes4
Dr. Scott's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2882024: 25910%
- Surgery
- 2023: 952024: 8412%
- Tests and treatments
- 2023: 252024: 0100%
Dr. Scott compared with the New York median for nephrologists, 2024
- Dr. Scott
- New York median
- Medicare services
- 343vs 68950% below
- Medicare patients
- 54vs 21775% below
- Part D claims
- 1,677vs 4363.8 times
Medians across 892 nephrologists in New York with Dmand AI profiles that report each measure.
Dr. Scott's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Scott?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Scott and other nephrologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David Scott III treated 54 Medicare patients in 2024, average age 75
CMS counts 54 Medicare patients who saw Dr. Scott in 2024. The largest group is 75 to 84, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Scott's median patient age at 66, with 53% women.
Medicare patients, 202454
Average age75
Average risk score2.98
Also on Medicaid26%
Dr. Scott's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Scott's Medicare patients by sex, 2024
- Women3565%
- Men1935%
Chronic conditions among Dr. Scott's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Chronic kidney disease72%
- Diabetes67%
- Arthritis59%
- Ischemic heart disease37%
- Heart failure31%
- Cancer26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Scott's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women53%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David Scott III wrote 2,166 Medicare Part D claims in 2024
In 2024, Dr. Scott wrote 2,166 Medicare Part D claims for 175 patients. 77% of them were for generic drugs. CMS names the drug for 1,677 of them, across 58 drugs with 11 or more claims each, at $241,590 in total drug cost. In 2023, CMS named 1,482 claims across 54 drugs.
Part D claims, 20242,166
Drugs named by CMS58
Total drug cost$241,590
Part D patients175
Dr. Scott's Part D claims by kind of drug, 2024
- Generic1,672 claims77%
- Brand-name452 claims21%
- Other42 claims2%
Dr. Scott's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Scott's Part D claims, 2024
- Antibiotics1%23 of 2,166 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,4822024: 1,67713%
Drugs named by CMS: 58 in 2024, 54 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. David Scott III takes part in Medicare
Dr. Scott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find nephrologists like Dr. Scott by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David Scott III has 247 publications on record
Dmand AI links 247 papers to Dr. Scott, published from 2009 to 2025. 2023 was the busiest year, with 20. The most frequent topics are Sarcopenia, Muscle Strength and Bone Density. Dr. Scott has published most often in J Cachexia Sarcopenia Muscle. Dr. Scott's most frequent co-authors are Alexander Rodriguez, MD, David J. Castle, DO and Michael D. Connolly, MD.
Papers247
Years published2009 to 2025
Dr. Scott's papers by year, 2016 to 2025
Topics Dr. Scott writes about most
- Sarcopenia
- Muscle Strength
- Bone Density
- Obesity
- Australia
- Hand Strength
- Absorptiometry, Photon
- Accidental Falls
Dr. Scott's most frequent co-authors
- Alexander Rodriguez, MD4 shared papers
- David J. Castle, DO2 shared papers
- Michael D. Connolly, MD2 shared papers
Recent publications by Dr. Scott
Bone Density Conservation AgentsFeasibility StudiesHealth Knowledge, Attitudes, Practice
Arch Gerontol Geriatr
Australasian PeopleAustraliaExercise
See who Dr. Scott researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Scott works with, so you can find a warm path to the right nephrologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Scott III has worked on 4 clinical trials
Dmand AI links Dr. Scott to 4 clinical trials. Conditions studied include Colitis, Ulcerative, Colitis and Headache. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Scott that name 4 trials.
Conditions in Dr. Scott's trials
- Colitis, Ulcerative
- Colitis
- Headache
- Renal Insufficiency, Chronic
- Migraine Disorders
Investigators on the most trials with Dr. Scott
- Bincy Paulose Abraham, MD2 shared trials
- Waqqas Afif, MD2 shared trials
- Yasmin Alishahi, MD2 shared trials
Recent clinical trials with Dr. Scott
$3,508 in research paymentsRenal Insufficiency, ChronicRenal InsufficiencySotagliflozin
$681 in research paymentsColitis, UlcerativeColitisMirikizumab
$150 in research paymentsHeadacheMigraine DisordersGalcanezumab
$28 in research paymentsColitis, UlcerativeColitisMirikizumab IVMirikizumab SC
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Scott III received $7,247 in industry payments from 2016 to 2025
CMS Open Payments shows 42 general payments to Dr. Scott from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,212. It also lists 6 research payments totaling $4,368 from 2016 to 2020, naming 4 clinical trials.
General payments to Dr. Scott by program year, 2016 to 2025
General payments to Dr. Scott by kind, 2016 to 2025
$7.2Kin total
- Consulting fees$3,36346%
- Travel and lodging$2,48834%
- Food and beverage$1,37719%
- Education$200%
Companies that paid Dr. Scott the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David Scott III graduated from Tufts University School of Medicine
Dr. Scott graduated from Tufts University School of Medicine in 1985.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. David Scott III's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Scott III
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Scott III's NPI number?
Dr. David Scott III's NPI number is 1730281452. It was assigned on September 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David Scott III?
Dr. David Scott III is a nephrologist in Rosedale, New York. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. David Scott III practice?
Dr. Scott practices at 1 Cross Island Plz, Rosedale, NY 11422. Dr. Scott's primary practice is Nephrology and Internal Medicine Specialist in Rosedale, New York. Dmand AI also links Dr. Scott to 1 dialysis center and 1 physician office.
What is Dr. David Scott III's office phone number?
The practice phone on file for Dr. Scott is (718) 276-4750.
What is Dr. David Scott III's medical license number?
Dr. Scott holds New York license 176037-1.
Does Dr. David Scott III accept Medicare?
Yes. CMS data shows Dr. Scott billed Medicare for 343 services in 2024, and Dr. Scott accepts Medicare assignment.
How many Medicare patients does Dr. David Scott III see?
CMS counts 54 Medicare patients who saw Dr. Scott in 2024, with an average age of 75.
What services does Dr. David Scott III bill to Medicare?
In 2024, Dr. Scott's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and surgery: heart and blood vessels (36415).
Where did Dr. David Scott III go to medical school?
Dr. Scott graduated from Tufts University School of Medicine in 1985.
What drugs does Dr. David Scott III prescribe most?
In 2024 Medicare Part D data, Dr. Scott's most prescribed drugs by claims were Farxiga, Amlodipine Besylate and Atorvastatin Calcium.
Show 4 more questionsShow fewer questions
Has Dr. David Scott III received payments from drug or device companies?
CMS Open Payments shows $7,247 in general payments to Dr. Scott from 19 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. David Scott III been practicing?
Dr. Scott graduated from medical school in 1985, 41 years ago.
Does Dr. David Scott III do research?
Dmand AI links 247 publications to Dr. Scott, published from 2009 to 2025. Dr. Scott has worked on 4 clinical trials.
Who does Dr. David Scott III publish with?
Dr. Scott's most frequent co-authors are Alexander Rodriguez, MD (4 shared papers), David J. Castle, DO (2 shared papers) and Michael D. Connolly, MD (2 shared papers).
Selling to nephrology practices?
See nephrologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card